Free Trial

Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 12.3% - Should You Sell?

Sino Biopharmaceutical logo with Medical background

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF - Get Free Report)'s share price fell 12.3% during trading on Thursday . The stock traded as low as $0.37 and last traded at $0.37. 202 shares changed hands during trading, a decline of 95% from the average session volume of 4,229 shares. The stock had previously closed at $0.42.

Sino Biopharmaceutical Stock Performance

The firm has a 50-day moving average price of $0.42 and a 200 day moving average price of $0.41.

Sino Biopharmaceutical Company Profile

(Get Free Report)

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.

Featured Articles

Should You Invest $1,000 in Sino Biopharmaceutical Right Now?

Before you consider Sino Biopharmaceutical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sino Biopharmaceutical wasn't on the list.

While Sino Biopharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Volatility-Proof Your Portfolio with These 7 ETFs

Volatility-Proof Your Portfolio with These 7 ETFs

Looking to reduce the volatility of individual stocks? ETFs offer exposure to dozens of companies, smoothing out the ups and downs of the market.

Recent Videos

NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
7 High-Growth Stocks Under $10
These Are the 3 Stocks Most Likely to SPLIT in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines